Colony Stimulating Factor-1 Receptor Blocker [EPC] class drugs

1 result
  • niktimvo - axatilimab - csfr injection

    (Axatilimab-Csfr)
    Incyte Corporation
    Niktimvo treats chronic graft-versus-host disease (cGVHD) in adults and pediatric patients weighing at least 40 kg, after at least two prior systemic therapies have failed.